September 12, 2025 · Form 4 insider transaction
Schaeffer Orlov S Nicole bought 56,520 shares of Insmed Incorporated at $23.75 per share, a transaction worth $1.34M. The trade was recorded as option exercise under a pre-scheduled Rule 10b5-1 plan and disclosed on an SEC Form 4, filed 3 days after the transaction.
This transaction was effected pursuant to a 10b5-1 trading plan adopted by the Reporting Person on June 13, 2025, in accordance with Rule 10b5-1 of the Securities Exchange Act of 1934, as amended.